Company / AR per Share
Bio-Rad Laboratories AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$15.77
FY2025
5-year range
$14.03 / $16.40
FY2021-FY2025
Trend
+3.8%
vs FY2024
Sector context
#12 of 136
Health Care
What the data says
Among 136 Health Care companies, Bio-Rad Laboratories is in the top 9% for ar per share. AR per Share returned to growth in FY2025 after 2 years of decline, reaching $15.77.
Based on SEC 10-K filings.
15.77 in FY2025 with a 5-year CAGR of +2.6%. Top quartile in the Health Care sector.
Declined from $16.19 to $15.77 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -1.3%
- 5-Year CAGR
- +2.6%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 136This company $15.77 Sector average $12.05
▼
+30.9% above sector average
Key checks
Key Insights
- In FY2025, ar per share increased 3.8% year-over-year.
- Ranks #12 out of 136 companies in the Health Care sector.
- Peak ar per share was recorded in FY2022.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.77 | +3.8% |
| FY2024 | $15.19 | -6.2% |
| FY2023 | $16.19 | -1.3% |
| FY2022 | $16.40 | +16.9% |
| FY2021 | $14.03 | +1.1% |
| FY2020 | $13.88 | +6.1% |
| FY2019 | $13.07 | -1.2% |
| FY2018 | $13.24 | -16.3% |
| FY2017 | $15.81 | +23.7% |
| FY2016 | $12.78 | -5.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026